The 10 drugs that CMS might wrangle into negotiations
(By Paige Twenter for Becker’s Hospital Review ) CMS plans to soon release its list of 10 drugs that are
Read More
Drug-pricing
This Panel Will Decide Whose Medicine to Make Affordable. Its Choice Will Be Tricky
(By Markian Hawryluk for KFF Health News) Catherine Reitzel’s multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies
Read MorePBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention
(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the
Read MoreHow Medicare drug pricing changes could affect commercial plans: 3 things to know
(By Rylee Wilson for Becker’s Hospital Review ) The drug-pricing provisions of the Inflation Reduction Act only apply directly to
Read More